Alicja Januszewicz
Director/Board Member at Women In The Enterprise of Science & Technology
Profile
Alicja Januszewicz is currently the Director at Women In The Enterprise of Science & Technology.
Previously, she worked as the Head of Talent Management at Baxter International, Inc. from 2015 to 2016 and at Epizyme, Inc. from 2007 to 2013.
She also served as the Vice President of People & Culture at Allena Pharmaceuticals, Inc. Additionally, she is currently the Senior Vice President of People & Culture at Theseus Pharmaceuticals, Inc. from 2021 to 2022.
Dr. Januszewicz holds a doctorate from the Polish Academy of Sciences and an undergraduate degree from Kenan-Flagler Business School.
Alicja Januszewicz active positions
| Companies | Position | Start |
|---|---|---|
Women In The Enterprise of Science & Technology
 Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Director/Board Member | - |
Former positions of Alicja Januszewicz
| Companies | Position | End |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Human Resources Officer | 2022-10-31 |
| BAXTER INTERNATIONAL INC. | Human Resources Officer | 2016-10-31 |
| EPIZYME, INC. | Corporate Officer/Principal | 2012-12-31 |
| ALLENA PHARMACEUTICALS, INC. | Human Resources Officer | - |
Training of Alicja Januszewicz
| Polish Academy of Sciences | Doctorate Degree |
| Kenan-Flagler Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Commercial Services |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Alicja Januszewicz
